Menu Search
Equities

Rockwell Medical Inc

RWMA:BER

Rockwell Medical Inc

Actions
  • Price (EUR)4.46
  • Today's Change0.204 / 4.79%
  • Shares traded500.00
  • 1 Year change+157.14%
  • Beta--
Data delayed at least 15 minutes, as of Nov 11 2024 12:05 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers around the world. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.

  • Revenue in USD (TTM)94.37m
  • Net income in USD-4.77m
  • Incorporated2019
  • Employees237.00
  • Location
    Rockwell Medical Inc30142 WIXOM ROADWIXOM 48393United StatesUSA
  • Phone+1 (248) 960-9009
  • Fax+1 (302) 655-5049
  • Websitehttps://www.rockwellmed.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.